Turnstone Biologics Corp Stock Probability of Future Stock Price Finishing Over 0.55
| TSBX Stock | 0.55 0.03 5.77% |
Turnstone |
Turnstone Biologics Target Price Odds to finish over 0.55
The tendency of Turnstone Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.55 | 90 days | 0.55 | about 44.94 |
Based on a normal probability distribution, the odds of Turnstone Biologics to move above the current price in 90 days from now is about 44.94 (This Turnstone Biologics Corp probability density function shows the probability of Turnstone Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 3.16 . This usually implies as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Turnstone Biologics will likely underperform. Additionally Turnstone Biologics Corp has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Turnstone Biologics Price Density |
| Price |
Predictive Modules for Turnstone Biologics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Turnstone Biologics Corp. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Turnstone Biologics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Turnstone Biologics is not an exception. The market had few large corrections towards the Turnstone Biologics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Turnstone Biologics Corp, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Turnstone Biologics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.73 | |
β | Beta against Dow Jones | 3.16 | |
σ | Overall volatility | 0.08 | |
Ir | Information ratio | -0.09 |
Turnstone Biologics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Turnstone Biologics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Turnstone Biologics Corp can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Turnstone Biologics generated a negative expected return over the last 90 days | |
| Turnstone Biologics has high historical volatility and very poor performance | |
| Turnstone Biologics has some characteristics of a very speculative penny stock | |
| Turnstone Biologics has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 19.31 M. Net Loss for the year was (55.2 M) with profit before overhead, payroll, taxes, and interest of 71.13 M. | |
| Turnstone Biologics generates negative cash flow from operations | |
| Turnstone Biologics has a poor financial position based on the latest SEC disclosures | |
| About 66.0% of the company shares are owned by institutional investors | |
| Latest headline from thelincolnianonline.com: Turnstone Biologics Posts Quarterly Earnings Results |
Turnstone Biologics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Turnstone Stock often depends not only on the future outlook of the current and potential Turnstone Biologics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Turnstone Biologics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 11.6 M | |
| Cash And Short Term Investments | 94.8 M |
Turnstone Biologics Technical Analysis
Turnstone Biologics' future price can be derived by breaking down and analyzing its technical indicators over time. Turnstone Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Turnstone Biologics Corp. In general, you should focus on analyzing Turnstone Stock price patterns and their correlations with different microeconomic environments and drivers.
Turnstone Biologics Predictive Forecast Models
Turnstone Biologics' time-series forecasting models is one of many Turnstone Biologics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Turnstone Biologics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Turnstone Biologics Corp
Checking the ongoing alerts about Turnstone Biologics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Turnstone Biologics Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Turnstone Biologics generated a negative expected return over the last 90 days | |
| Turnstone Biologics has high historical volatility and very poor performance | |
| Turnstone Biologics has some characteristics of a very speculative penny stock | |
| Turnstone Biologics has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 19.31 M. Net Loss for the year was (55.2 M) with profit before overhead, payroll, taxes, and interest of 71.13 M. | |
| Turnstone Biologics generates negative cash flow from operations | |
| Turnstone Biologics has a poor financial position based on the latest SEC disclosures | |
| About 66.0% of the company shares are owned by institutional investors | |
| Latest headline from thelincolnianonline.com: Turnstone Biologics Posts Quarterly Earnings Results |
Additional Tools for Turnstone Stock Analysis
When running Turnstone Biologics' price analysis, check to measure Turnstone Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Turnstone Biologics is operating at the current time. Most of Turnstone Biologics' value examination focuses on studying past and present price action to predict the probability of Turnstone Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Turnstone Biologics' price. Additionally, you may evaluate how the addition of Turnstone Biologics to your portfolios can decrease your overall portfolio volatility.